contents
Haematology and oncology
89
Targeting optimal care, together
Umberto Ricardi
91
Anti-GD2 mAbs for the treatment
of high-risk neuroblastoma
Jaume Mora
97
Evolving protection in haemophilia
Swedish Orphan Biovitrum
101
Oral anticoagulants
and cancer-associated thrombosis
Guy Meyer
103
CAR T-cell therapy:
managing side effects
Tiene Bauters
106
Perspectives for treating
cancer-associated thrombosis
Paolo Prandoni and Andrea Piccioli
108
Implications of licensed
standardised chemotherapy doses
and their potential impact
Tariro Kabba and
Christopher Woodard
87
HHE 2018 | hospitalhealthcare.com